| Literature DB >> 29023404 |
Sergio G Hernandez-Leon1, Jose Andre-I Sarabia-Sainz2, Gabriela Ramos-Clamont Montfort3, Ana M Guzman-Partida4, Maria Del Refugio Robles-Burgueño5, Luz Vazquez-Moreno6.
Abstract
Silica nanoparticles were functionalized with immobilized molecular bait,Entities:
Keywords: Cibacron Blue; functionalized core-shell silica nanoparticles; high molecular weight proteins; hydrophobic; low molecular weight proteins/peptides
Mesh:
Substances:
Year: 2017 PMID: 29023404 PMCID: PMC6151791 DOI: 10.3390/molecules22101712
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Schematic illustration of the strategy used for the synthesis of functionalized core-shell silica nanoparticles (FCSNP).
Size and zeta potential of the silica nanoparticles at each stage of synthesis. Values are expressed as the mean ± standard deviation (SD) of three samples, each measured in triplicate.
| Stage of Synthesis | ||||
|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |
| Silica Nanoparticles | APTES and Monomer | Cibacron Blue | FCSNP | |
| Size ± SD (nm) | 138.9 ± 5.6 | 218.4 ± 4.7 | 211.5 ± 18.1 | 243.9 ± 11.6 |
| Zeta potential ± SD (mV) | −47 ± 0.7 | −34.2 ± 1.5 | −54.6 ± 0.5 | −38.1 ± 0.9 |
SD = Standard deviation; APTES = 3-aminopropyl triethoxysilane; Monomer = 3-(trimethoxysilyl) propyl methacrylate; FCSNP = Functionalized core-shell silica nanoparticles.
Figure 2ATR-FTIR of the powders prepared from the nanoparticles at every stage of synthesis. (A) Corresponds to pure silica nanoparticles “S”; (B) is S + APTES “A” + monomer “M”; (C) is S + A + M + Cibacron blue “CB”; and (D) is S + A + M + CB + bis-acrylamide (FCSNP).
Figure 3Morphological characterization of the first stage of synthesis of silica nanoparticles by scattering electron microscopy. Nanoparticles are spherical, with a diameter of ~140 nm, and are homogeneous.
Figure 4Morphological characterization of FCSNP by transmission electron microscopy. Particles are spherical, with a diameter of ~250 nm, and a polymeric shell is formed at the surface (white arrows). (a) and (b) were obtained at 3 K and 30 K magnifications, respectively.
Analysis by UHPLC-Q-ToF of wash and elutions from FCSNP after incubation with model peptides.
| Peptide Sequence | Theoretical Mass (Da) | Experimental | Error (Da) | |
|---|---|---|---|---|
| Wash* with 50 mM phosphate buffer | Consecutive elutions ** with 50% isopropanol, 50% Methanol and ACN + NH4OH *** | |||
| 1. YSSK | 965.49 | −0.4352 | ||
| 965.06 | (M + H)1+ | |||
| Not eluted | ||||
| 483.2519 | 0.5562 | |||
| (M + 2H)2+ | ||||
| 2. | ||||
| N | ||||
| QS | 3646.32 | 1216.3632 | 1216.3632 | 0.2304 |
| S | (M + 3H)3+ | (M + 3H)3+ | ||
1 = Nonapeptide; 2 = Alpha zein 34-mer; * = No interaction with Cibacron blue; ** = Interaction with Cibacron blue; *** = 70% acetonitrile + 20% ammonium hydroxide.
Figure 5SDS-PAGE analysis of model proteins captured by FCSNP with (+CB) and without (−CB) Cibacron Blue. Model proteins, myoglobin, 17 kDa, and aprotinin, 6.5 kDa (lane 1); wash with PB (lanes 2 and 6); elution with 50% isopropanol (3 and 7); elution with 50% methanol (lanes 4 and 8), elution with ACN + NH4OH (lanes 5 and 9). Model proteins were obtained only in the elutions with 50% methanol and ACN + NH4OH with the +CB nanoparticles, and were absent from similar elutions with the −CB nanoparticles.
Figure 6SDS-PAGE analysis of the FCSNP washes and elutions after incubation with high and low molecular weight model proteins for 60 min. Model proteins BSA (66 kDa), myoglobin (17 kDa), and aprotinin (6.5 kDa) (lane 1). Excess of proteins was removed in wash with PB (lane 2) and elution with 50% isopropanol (lane 3). Simultaneous exclusion of albumin and capture of myoglobin and aprotinin was achieved in elutions with 50% methanol and ACN + NH4OH (lanes 4 and 5, respectively).
Capacity of the nanoparticles. FCSNP were incubated with different model proteins. Values are expressed as mean ± standard deviation (SD) from measures by triplicate.
| Model Protein | Capacity of FCSNP (µg/mg) |
|---|---|
| Aprotinin | 3.4 ± 0.15 |
| Myoglobin | 3.1 ± 0.26 |
FCSNP = Functionalized core-shell silica nanoparticles; Capacity of FCSNP (µg/mg) = amount of protein (µg) captured per milligram of nanoparticles.